HSN Code 30024111: Single Vaccines: Cholera and Typhoid

HSN Code 30024111 represents Single Vaccines: Cholera and Typhoid under GST classification. This code helps businesses identify Single Vaccines: Cholera and Typhoid correctly for billing, taxation, and trade. With HSN Code 30024111, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import or export of Single Vaccines: Cholera and Typhoid.

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

Description of Goods for HSN Code 30024111

HSN Code 30024111 relates to the following description.

Description of Goods

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid

Chapter

30 - Pharmaceutical products

Sub Chapter

3002 - Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified

CGST

2.5%

SGST

2.5%

IGST

5%

CESS

0%

What does HSN Code 30024111 not include?

Single Vaccines: Cholera and Typhoid does not include products with the following descriptions.

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other

Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins

India’s Trade Performance — HSN Code 30024111 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹580 Cr

+108.10% vs FY 2023-24

0.0157% of India’s total exports

India’s Imports

FY 2024-25

Nil

First year of recorded data

0.0000% of India’s total imports

Trade Balance

FY 2024-25

₹580 Cr

Trade Surplus

Surplus rank #554 of 12657 HSN codes

% of Sub-Chapter 3002

FY 2024-25

3.85%

Share of Sub-Chapter 3002’s total exports in FY 2024-25

Import side: 0.00% of Sub-Chapter 3002’s imports

Rank Within Sub-Chapter 3002

FY 2024-25

#7 of 61

Position by export value among HSN codes in Sub-Chapter 3002

At a glance

#887

National Export Rank

of 12657 HSN codes by export value, FY 2024-25

+108.10%

Peak Growth Year

FY 2024-25 · strongest single-year move

3.85%

Contribution to Sub-Ch. 3002

Share of Sub-Chapter 3002 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Code 30024111

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19

Balance

0.00

Exports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2019-20

Balance

0.00

Exports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2020-21

Balance

0.00

Exports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2021-22

Balance

0.00

Exports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2022-23 Exp. Rank #1173

Balance

+360.75

Exports

360.75 ₹ Cr

0.0100% share

YoY

3.06% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2023-24 Exp. Rank #1450

Balance

+278.54

Exports

278.54 ₹ Cr

0.0077% share

−22.79% YoY

2.00% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

FY 2024-25 Exp. Rank #887

Balance

+579.64

Exports

579.64 ₹ Cr

0.0157% share

+108.10% YoY

3.85% of Sub-Ch. 3002

Imports

Nil ₹ Cr

0.0000% share

YoY

0.00% of Sub-Ch. 3002

Sub-Chapter 3002 total

reference, FY 2024-25

Export

₹15,063.17 Cr

Import

₹11,034.41 Cr

Trade Balance

+4,028.76

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Code 30024111 Export-Import Analysis

Export Snapshot for HSN Code 30024111

India exported ₹579.64 Crore worth of Single Vaccines: Cholera and Typhoid in FY 2024-25. Multi-year trend data is being compiled for this hsn code.

HSN Code 30024111 Ranked #887 Among All 12657 HSN codes by Export Value

In FY 2024-25, HSN Code 30024111 ranks #887 out of 12657 HSN codes by total export value. Within Sub-Chapter 3002, it ranks #7 of 61. By trade surplus, it ranks #554 of 12657.

FY 2024-25 Was the Strongest Growth Year for HSN Code 30024111 Exports

The strongest single-year export movement for HSN Code 30024111 was recorded in FY 2024-25, when exports surged by 108.10% over the prior year.

India Maintains a Trade Surplus of ₹579.64 Crore in HSN Code 30024111 Goods

In FY 2024-25, India's exports of ₹579.64 Cr exceeded imports of ₹0.00 Cr, resulting in a trade surplus of ₹579.64 Crore — ranking #554 of 12657 by surplus magnitude.

HSN Code 30024111 Contributes 3.85% of Sub-Chapter 3002 Exports — Ranked #7

Among the 61 HSN codes under Sub-Chapter 3002, HSN Code 30024111 ranks #7 by export value — accounting for 3.85% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.00% share.

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Code 30024111 and GST compliance.

What products are classified under HSN 30024111 ?

It includes Single Vaccines: Cholera and Typhoid

How much GST applies to Single Vaccines: Cholera and Typhoid?

Under HSN 30024111, Single Vaccines: Cholera and Typhoid attracts Varies when sold in taxable form. Describe the exact form on the invoice.

Does packaging or labelling change the GST for Single Vaccines: Cholera and Typhoid?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

Any common misclassification issue with Single Vaccines: Cholera and Typhoid?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

How should mixed supplies be billed when Single Vaccines: Cholera and Typhoid is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Single Vaccines: Cholera and Typhoid; Nil for exempt items if applicable).

Do e‑way bill and e‑invoice apply for Single Vaccines: Cholera and Typhoid?

e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.